Learn more about whether Artivion, Inc. or QuidelOrtho Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
The neurosurgeons say this marks a paradigm shift in how complex neurovascular interventions can safely be delivered.
The REC-CAGEFREE I trial1 by Chao Gao and colleagues describes the results of a multicentre trial in which a paclitaxel drug-coated balloon (DCB) did not reach expected non-inferiority compared with a ...
Dr. Christopher Busken with Northeast Baptist Hospital has performed surgeries for about 15 years to help people who suffer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback